Dr. Michael Xuan Le, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-721-4740 Fax: 717-738-6872 |
William D Loretan, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 446 N Reading Rd, Suite 301, Ephrata, PA 17522 Phone: 717-733-6546 Fax: 717-733-6011 |
Heather D Mccord, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-721-4740 Fax: 717-738-6872 |
Dr. Il Jun Chon, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 446 N Reading Rd, Suite 301, Ephrata, PA 17522 Phone: 717-733-6546 Fax: 717-733-6010 |
Marino D Mallozzi, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 446 N Reading Rd, Suite 301, Ephrata, PA 17522 Phone: 717-733-6546 Fax: 717-733-6010 |
Abdul Majeed, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-721-4740 Fax: 717-738-6872 |
Kunal N Patel, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-721-4740 Fax: 717-738-6872 |
Ting Ting Wang, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-721-4740 Fax: 717-738-6872 |
Dr. Richa Neupane, Hospitalist Medicare: Medicare Enrolled Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-721-4740 Fax: 717-738-6872 |
News Archive
A landmark report on the Global Economic Impact of Dementia finds that Alzheimer's disease and other dementias are exacting a massive toll on the global economy, with the problem set to accelerate in coming years. The World Alzheimer Report 2010 - issued on World Alzheimer's Day by Alzheimer's Disease International (ADI) - provides the most current and comprehensive global picture of the economic and social costs of the illness.
A new study by UNC Charlotte scholars is shedding light on the connection between diet and a common childhood disease.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Gabapentin Tablets USP, 600 mg and 800 mg, the generic version of Pfizer's Neurontin Tablets for the treatment of postherpetic neuralgia, a complication of shingles.
An increase in the number of trips to the bathroom - day or night - is a signal it's time to see a physician.
› Verified 6 days ago